BNP Fragment EIA

Biomedica

Human BNP Fragment EIA

7

ELISA

200-6400 pmol/l

intra-assay: 8%, inter-assay: 7%

serum, EDTA plasma, heparın plasma, citrate plasma

171 pmol/l

human BNP Fragment (8-29)

Competitive EIA

overnight assay

Assay

Research Use Only

Product Characteristics: The Biomedica human BNP Fragment EIA kit is a test that is intended for the quantitative measurement of B-type natriuretic peptide levels in human serum, EDTA plasma, citrate plasma and heparin plasma. The Biomedica BNP Fragment EIA is a highly recognized test with >60 BNP Fragment ELISA specific publications to date. Target Information: BNP is mainly expressed by ventricular myocardium in response to volume overload and increased filling pressure. BNP has a cleavable signal sequence. Mature BNP consists of 108 amino acids (proBNP or BNP-108), and undergoes cleavage resulting in physiologically active BNP-32 and additional C-terminal fragments, along with a physiologically inactive N-terminal peptide comprising amino acids 1-76, which is further degraded proteolytically. BNP has a key role in cardiovascular homeostasis with biological actions including natriuresis, diuresis, vasorelaxation, and inhibition of renin and aldosterone secretion. A high concentration of BNP in the bloodstream is indicative of heart failure.

2-8°C

41116133